San Jose, CA, August 19, 2020: OptraHEALTH®, a leading data-driven intelligence company, announced the collaboration with Johns Hopkins University for its flagship product GeneFAX™ for developing digital tools for patients. GeneFAX™ is an AI-powered, HIPAA-compliant knowledge platform for genetic health with BOT interfaces. This new-gen AI platform is suitable for educating patients, gathering their interest in various genetic tests, patient consenting, triaging, and pre-test and post-test counseling.
“In this ever-changing society, the most powerful healthcare technologies are built passionately revolving around better patientcare. We are delighted to announce our collaboration with Johns Hopkins University. GeneFAX™ advanced AI technology coupled with JHUs world-class clinicians and scientists will enable novel access to genetic education and appropriate genetic testing while maintaining patient satisfaction” said Dr. Gauri Naik, Co-Founder & CEO, OptraHEALTH, Inc.
OptraHEALTH® is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing our next-generation Artificial Intelligence Platform. OptraHEALTH’s flagship product GeneFAX™ is an AI-powered Knowledge Platform for Genetic Health and is available as a Web Plugin or Mobile application.